Clinical Trial Update: Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing insulin glulisine with regular human insulin in adults with Type 2 diabetes completed, assessing postprandial endothelial function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Apidra (insulin glulisine)
• Humulin R

Snippet

Sponsor: IKFE Institute for Clinical Research and Development | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED